NWL-283

N/A

Report date: 2024/10/29 14:39:47
NME

Base Information

Drug NameNWL-283
Drug Alias NameNWL-283
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 modulators
TargetsCaspase-3
Therapy Area/IndicationsMyocardial InfarctionSpinal Cord InjuriesAlzheimer Disease +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew World Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesNew World Laboratories
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionSpinal Cord InjuriesAlzheimer Disease +[8
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A